In Vitro Diagnostics Industry Overview The global in vitro diagnostics market size is expected to reach USD 113.38 billion by 2030, according to a new report by Grand View Research, Inc. It is estimated to register a CAGR of 0.2% over the forecast period driven by the increasing geriatric population, COVID-19 pandemic, and technological advancements in diagnostics that are supporting its adoption. Technological advancements in terms of portability, accuracy, and cost-effectiveness are projected to be one of the high-impact rendering drivers. Technological advancements were further accelerated by the launch of COVID-19 IVD diagnostics and enhanced the adoption of instruments and consumables for technologies, such as PCR. Competitors in the market are increasingly adopting agreement and partnership strategies to maintain a constant flow of business for manufacturers & diagnostics for users. In Vitro Diagnostics Market Segmentation Grand View Research has segmented the global in vitro diagnostics market based on product, technology, application, end-use, test location, and region: Based on the Product Insights, the market is segmented into Instruments, Reagents, Services.
Based on the Technology Insights, the market is segmented into Immunoassay, Hematology, Clinical Chemistry, Molecular Diagnostics, Coagulation, Microbiology, Others.
Based on the Application Insights, the market is segmented into Infectious Disease, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Disease, Drug Testing, Others.
Based on the End-use Insights, the market is segmented into Hospitals, Laboratories, Home Care, Others.
Based on the Test Location Insights, the market is segmented into Point of Care, Home Care, Others.
In Vitro Diagnostics Regional Outlook
Key Companies Profile & Market Share Insights Market players undertake this strategy to strengthen their product portfolios and offer diverse technologically advanced & innovative products to their customers. In January 2021, Abbott received FDA approval for its rapid handheld Traumatic Brain Injury (TBI) blood test. The first-of-its-kind test is used for assessing mild TBIs and concussions in patients. Some prominent players in the global In vitro diagnostics market include
Order a free sample PDF of the In Vitro Diagnostics Market Intelligence Study, published by Grand View Research.
0 Comments
Leave a Reply. |
Archives
December 2023
Categories |